FIELD: cellulose and cellulose derivatives.
SUBSTANCE: invention relates to powdered cellulose characterized by average degree of polymerization 150-450, average particle diameter 30-250 μm, apparent specific volume exceeding 7 cm3/g, and retention capacity regarding polyethylene glycol with molecular mass 400 at a level of 190% or higher. Group of inventions also comprises method of preparing powdered cellulose and composition for a molded product.
EFFECT: enlarged assortment of cellulose materials.
3 cl, 4 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CELLULOSE-CONTAINING COMPOSITION, TABLET AND TABLET WITH INTRAORAL DISINTEGRATION | 2019 |
|
RU2796502C1 |
| CELLULOSE-CONTAINING COMPOSITION AND TABLET | 2019 |
|
RU2798266C1 |
| COMPRESSED PHARMACEUTICAL PRODUCT | 2016 |
|
RU2744270C2 |
| CONTROLLED RELEASE SOLID PREPARATION | 2006 |
|
RU2496480C2 |
| TABLET, WHICH IS DECOMPOSED IN MOUTH | 2008 |
|
RU2478375C2 |
| SOLID PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152802C2 |
| HARD MEDICATION | 2006 |
|
RU2426530C2 |
| PILL CONTAINING METHANESULFONATE HYDRATE OF 1-CYCLOPROPYL-8-(DIFLUOROMETHOXY)-7-[(1R)-1-METHYL-2,3-DIHYDRO-1H-ISOINDOLE-5-YL]-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | 2012 |
|
RU2633477C2 |
| ENTERIC-COATED TABLET | 2011 |
|
RU2593771C2 |
| TABLETED PHARMACEUTICAL COMPOSITION AND METHOD OF ITS MAKING | 1997 |
|
RU2180219C2 |
